Oncolytic adenoviruses armed with co-stimulatory molecules for cancer treatment
A Gryciuk, M Rogalska, J Baran, L Kuryk… - Cancers, 2023 - mdpi.com
Simple Summary Current cancer therapies are insufficient to cure advanced malignancies
and cause off-target toxicity. Scientists have focused on developing new, more efficacious …
and cause off-target toxicity. Scientists have focused on developing new, more efficacious …
[PDF][PDF] Oncolytic Adenoviruses Armed with Co-Stimulatory Molecules for Cancer Treatment. Cancers 2023, 15, 1947. htps
A Gryciuk, M Rogalska, J Baran, L Kuryk… - doi. org/10.3390 …, 2023 - researchgate.net
In clinical trials, adenovirus vectors (AdVs) are commonly used platforms for human gene
delivery therapy. High genome capacity and flexibility in gene organization make HAdVs …
delivery therapy. High genome capacity and flexibility in gene organization make HAdVs …